U.S. infectious disease company IPO financing 2006-2022
In 2022, R&D stage emerging infectious disease companies in the U.S. raised 289 million dollars by going public. This graph shows the amount of money companies active in infectious disease reserach in the U.S. raised through initial public offerings from 2006 to 2022.